After the US Food and Drug Administration approval in 2002 of the first ever fully human mAb drug (AbbVie’s Humira (adalimumab)), fully human mAbs rapidly became the gold standard of mAb-based ...

I-Mab Biopharma (‘I-Mab’), headquartered in Shanghai, is different. From its inception in 2015, the company has been focused exclusively on discovering and developing innovative biologics ...

Programme will launch the implementation of the “Mangrove Restoration: Nature-Based Solutions in Biosphere Reserves of Latin America and the Caribbean” project (MangRes Project), thanks to the ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...